Having had setbacks with torcetrapib and Exubera, and with generic competition to Norvasc and Lipitor, Pfizer is putting more emphasis into animal drugs.
Related posts:
- Generics are killing Pfizer
- Pfizer gives up on cardiac drugs
- Desperate Pfizer going with ads to save failing Exubera
- RIP Torcetrapib
- Pfizer blows Exubera away
- How Pfizer plans to increase revenue
- Chantix: Pfizer’s golden goose?
KevinMD.com on Facebook
{ 1 comment }
I wonder if they sell veterinary Viagra in Enumclaw?
Comments on this entry are closed.